18 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Akari Therapeutics, Inc. AKTX shares surged 14.5% to $2.21 during Friday's pre-market session. The market cap stands at $28.6 million.
• Myovant Sciences, Inc. MYOV shares moved upwards by 14.0% to $9.45. The market cap seems to be at $782.9 million. The most recent rating by Goldman Sachs, on August 28, is at Buy, with a price target of $20.00.
• Cancer Genetics, Inc. CGIX shares rose 12.9% to $0.11. The market cap stands at $37.0 million.
• Community Health Systems, Inc. CYH stock surged 11.4% to $2.40. The market cap stands at $460.6 million.
• Evoke Pharma, Inc. EVOK stock surged 10.5% to $1.05.
• Paratek Pharmaceuticals, Inc. PRTK stock surged 8.0% to $3.66. The market cap seems to be at $589.5 million.
• Guardion Health Sciences, Inc. GHSI shares surged 4.7% to $0.26.
• AAC Holdings, Inc. AAC stock rose 3.1% to $0.67. The market cap stands at $18.9 million. According to the most recent rating by Raymond James, on August 13, the current rating is at Market Perform.
• Histogenics, Inc. HSGX stock moved upwards by 3.0% to $0.23. The market cap stands at $52.8 million.
• Evolus, Inc. EOLS shares increased by 2.3% to $16.11. The market value of their outstanding shares is at $579.1 million. The most recent rating by JMP Securities, on August 13, is at Market Outperform, with a price target of $30.00.
• Mallinckrodt, Inc. MNK shares moved upwards by 2.3% to $3.14. The most recent rating by Barclays, on August 28, is at Equal-Weight, with a price target of $5.00.
• Kitov Pharma, Inc. KTOV stock moved upwards by 2.0% to $0.88.
• Novartis, Inc. NVS shares rose 2.0% to $90.77.
• Dr Reddy's Laboratories, Inc. RDY shares rose 2.0% to $35.91. The market value of their outstanding shares is at $9.4 billion. The most recent rating by Barclays, on June 11, is at Equal-Weight, with a price target of $39.00.

Losers

• Alexion Pharmaceuticals, Inc. ALXN shares decreased by 8.0% to $103.20 during Friday's pre-market session. The market cap stands at $24.1 billion. According to the most recent rating by JP Morgan, on July 31, the current rating is at Overweight.
• Vical, Inc. VICL stock plummeted 5.2% to $0.76. The market cap seems to be at $16.2 million.
• Plus Therapeutics, Inc. PSTV shares declined 1.6% to $16.55. The market value of their outstanding shares is at $226.6 million.
• Novo Nordisk, Inc. NVO stock declined 1.4% to $51.89. According to the most recent rating by Jefferies, on August 30, the current rating is at Underperform.